Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.199 USD | -0.50% |
|
+20.61% | +42.14% |
20/05 | Elite Pharmaceuticals Receives Fda Approval for Generic Methotrexate | CI |
15/02 | Transcript : Elite Pharmaceuticals, Inc., Q3 2024 Earnings Call, Feb 15, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe1st Jan change | Capi. | |
---|---|---|
+42.14% | 21Cr | |
+20.45% | 4.38TCr | |
+30.16% | 2.28TCr | |
+20.25% | 1.56TCr | |
+18.53% | 1.43TCr | |
+54.90% | 1.3TCr | |
-0.05% | 678.76Cr | |
-11.72% | 641.27Cr | |
-8.87% | 572.55Cr | |
+14.65% | 568.66Cr |
- Stock Market
- Equities
- ELTP Stock
- News Elite Pharmaceuticals, Inc.
- Transcript : Elite Pharmaceuticals, Inc., Q2 2024 Earnings Call, Nov 15, 2023